Evidence map›Paper›PMID 30094226›Full record

ArticleFrontiers in cellular and infection microbiology2018

Artemisinin Derivatives and Synthetic Trioxane Trigger Apoptotic Cell Death in Asexual Stages of

Sarika Gunjan, Tanuj Sharma, Kanchan Yadav, Bhavana S Chauhan, Sunil K Singh, Mohammad I Siddiqi, Renu Tripathi

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Supercritical COBiotechnology notes (Amsterdam, Netherlands) · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Cell Death ofPathogens (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Progress in Redirecting Antiparasitic Drugs for Cancer Treatment.Drug design, development and therapy · 2021
    Review
  17. Recycling the Purpose of Old Drugs to Treat Ovarian Cancer.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarika GunjanAcademy of Scientific and Innovative Research, New Delhi, India.
Tanuj SharmaAcademy of Scientific and Innovative Research, New Delhi, India.
Kanchan YadavDivision of Parasitology, Central Drug Research Institute (CDRI), Council of Scientific and Industrial Research (CSIR), Lucknow, India.
Bhavana S ChauhanAcademy of Scientific and Innovative Research, New Delhi, India.
Sunil K SinghDivision of Parasitology, Central Drug Research Institute (CDRI), Council of Scientific and Industrial Research (CSIR), Lucknow, India.
Mohammad I SiddiqiAcademy of Scientific and Innovative Research, New Delhi, India.
Renu TripathiAcademy of Scientific and Innovative Research, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although over the last 15 years, prevalence of malaria became reduced by over half but developing resistance against artemisinin derivatives and its combinations, which are only ray of hope to treat resistant malaria set back the control efforts and the key hinderence to achieve the goal of malaria elimination till 2030. In spite these artemisinins are precious antimalarials, their action mechanism is yet to be fully understood. Reactive oxygen species (ROS) produces by cleavage of endoperoxide bridge of artemisinin derivatives are known to be its antimalarial efficacy. Since ROS could induce apoptosis, here we had explored the effect of artemisinin derivatives on apoptotic machinery of malaria parasite,

Indexed as

AntimalarialsApoptosisArtemisininsBlood CellsCell SurvivalHeterocyclic CompoundsHumansMembrane Potential, MitochondrialMitochondrial MembranesPermeabilityPlasmodium falciparumReactive Oxygen Species1,2,4-trioxaneAntimalarialsartemisininArtemisininsHeterocyclic CompoundsReactive Oxygen SpeciesapoptosisarteetherartesunateCDRI-97/78Plasmodium

Identifiers

PMID30094226
PMCPMC6070741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.